Pharmacists are often the first point of contact for patients navigating the complex world of medicines management, especially in the peri-procedural period. This is a critical time when patients are preparing for diagnostic or minor surgical procedures, and the last thing they need is confusion about their medications. In this article, we delve into the intricate dance of managing medicines before and after procedures, with a special focus on the challenges faced by patients using dose administration aids (DAAs).
The Peri-Procedural Puzzle
The case of David, a 68-year-old man, highlights the very real dilemma many patients encounter. With a complex medical history, including type 2 diabetes, hypertension, and atrial fibrillation, David's medication regimen is a web of interconnected drugs. The challenge arises when he receives conflicting instructions from the clinic, leaving him unsure about which medications to continue, stop, or restart. This scenario is not unique; it's a common occurrence in the realm of peri-procedural medicines management.
Pharmacists play a pivotal role in this intricate process. They are the navigators, guiding patients through the maze of medication adjustments, ensuring safety, and minimizing the risk of errors. But the task is not without its complexities.
Medicines in the Spotlight
The decision to withhold or continue medications during the peri-procedural period is a delicate balance. It involves considering the potential risks of the procedure, such as bleeding, infection, and interactions with other medications, against the risk of disease exacerbation or withdrawal effects. Pharmacists are the key to deciphering this puzzle.
Anticoagulants and Antiplatelet Agents
Anticoagulants and antiplatelet agents, such as warfarin and direct oral anticoagulants, are among the most frequently managed medications in this context. These drugs increase the risk of bleeding during procedures like colonoscopy and dermatological excisions. However, the decision to withhold them is highly individualized and should always be clinician-directed. Pharmacists can provide crucial support by reinforcing clear stop and restart dates and emphasizing the importance of timely recommencement.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs, commonly used for pain relief, present a nuanced risk-benefit scenario. While they can impair renal perfusion and increase the risk of bleeding, they are often safe to continue for minor procedures like cataract surgery. Pharmacists should proactively inquire about over-the-counter NSAID use and recommend suitable alternatives, such as paracetamol, to minimize the risk of renal impairment.
Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)
The management of ACEIs and ARBs is a clinical debate. Continuation may lead to intraoperative hypotension, while cessation may result in postoperative hypertension. An individualized approach is essential, considering the indication, baseline blood pressure, and the nature of the procedure. Pharmacists should reinforce clinicians' instructions and provide a rationale for temporary cessation, emphasizing the importance of timely recommencement.
Complementary and Herbal Products
The use of complementary and herbal products among surgical patients is prevalent, but disclosure to healthcare professionals is often incomplete. These products can exert significant pharmacodynamic and pharmacokinetic effects, increasing peri-procedural risk. Pharmacists should review these products, as their effects are not always predictable or dose-dependent. Many guidelines recommend discontinuing non-essential herbal medicines at least 1-2 weeks before procedures.
Diabetes Medicines and Blood Glucose Management
Medicines used to manage diabetes often require careful consideration during the peri-procedural period. Sodium-glucose co-transporter-2 (SGLT2) inhibitors, in particular, pose a unique challenge due to the risk of diabetic ketoacidosis (DKA), which can occur with near-normal or mildly elevated blood glucose levels. Pharmacists play a vital role in supporting patients and ensuring safe blood glucose management.
Managing DAAs: A Delicate Balance
Patients using DAAs face an increased risk of medication errors when medicines are changed, especially during the peri-procedural period. Pharmacists must take a proactive approach to managing these aids, ensuring that specific medicines are removed from affected doses and providing clear, written instructions. This includes outlining withheld medicines, monitoring advice during fasting, and the planned date of recommencement.
Knowledge to Practice
Community pharmacists can proactively review medicines before procedures, identify high-risk medications, and clarify clinician-directed instructions. They can also manage changes to DAAs, reinforce written advice, and support blood glucose monitoring during fasting or medicine withholding. By providing an accurate medicines list and encouraging patients to bring all medications for review, pharmacists can minimize confusion and prevent medicine-related harm.
Conclusion: The Pharmacist's Role
In the intricate world of peri-procedural medicines management, pharmacists are the guardians of patient safety. Their expertise in identifying high-risk medications, clarifying instructions, and providing practical support is invaluable. As the complexity of medicines management continues to grow, the role of pharmacists becomes increasingly vital, ensuring safe, coordinated, and patient-centered care.
